000			nab a22 7a 4500
999			_c17003 _d17003
003			PC17003
005			20221006122718.0
008			221006b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_91794 _aMedina Polo, José _eUrología
100			_92204 _aArrébola Pajares, Ana _eUrología
100			_92205 _aPérez Cadavid, Santiago _eUrología
100			_92264 _aBenítez Sala, Raúl _eUrología
100			_92595 _aSopeña Sutil, Raquel _eUrología
100			_92381 _aLara Isla, Alba _eUrología
100			_93051 _aAlonso Isa, Manuel _eUrología
100			_93092 _aGil Moradillo, Javier _eUrología
100			_92382 _aJusto Quintas, Juan _eUrología
100			_91935 _aMiranda Utrera, Natalia _e Urología
100			_93093 _aAguilar Gisbert, Luis _eUrología
100			_91929 _aPassas Martínez, Juan _eUrología
100			_9484 _aTejido Sánchez, Ángel _eUrología
245	0	0	_aExtended-Spectrum Beta-Lactamase-Producing Bacteria in a Urology Ward: Epidemiology, Risk Factors and Antimicrobial Susceptibility Patterns. _h[artículo]
260			_bUrologia internationalis, _c2015
300			_a95(3):288-92.
500			_aFormato Vancouver: Medina Polo J, Arrébola Pajares A, Pérez Cadavid S, Benítez Sala R, Sopeña Sutil R, Lara Isla A et al. Extended-Spectrum Beta-Lactamase-Producing Bacteria in a Urology Ward: Epidemiology, Risk Factors and Antimicrobial Susceptibility Patterns. Urol Int. 2015;95(3):288-92.
501			_aPMID: 26394031
504			_aContiene 22 referencias
520			_aIntroduction: Our aim was to describe the incidence and risk factors associated with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae and their resistance rate in a urological ward. Material and methods: We carried out a prospective observational study from November 2011 to December 2014, reviewing healthcare-associated infections (HAIs) in our department. We evaluated the infections caused by ESBL-producing Enterobacteriaceae. Results: The incidence of HAIs in our urology ward was 6.8%. Enterobacteriaceae including Escherichia coli (24.9%), Klebsiella spp. (12.1%), Enterobacter spp. (5.9%), Morganella spp. (1.5%), Proteus spp. (1.5%), and Citrobacter spp. (1.5%) represented 47.4% of the isolated pathogens. The percentage of ESBL-producing Enterobacteriaceae was 26.4. Risk factors associated with a higher incidence of ESBL-producing bacteria were prior urinary tract infection (UTI; p < 0.001), hypertension (p = 0.042), immunosuppression (p = 0.004), and urinary stone (p = 0.027). The multivariable analysis confirmed prior UTI, immunosuppression and urinary stone as risk factors. ESBL-producing strains showed resistance rates of 85.3% for fluoroquinolones and 11.8% for carbapenems. Moreover, 16.7% of ESBL-Klebsiella were resistant to carbapenems. Conclusions: ESBL-producing enterobacteria are associated with higher cross resistance to antibiotics such as quinolones. Higher resistance rates are reported in ESBL-producing Klebsiella. Among patients admitted in a urology ward, risk factors for ESBL-producing strains were previous UTI, immunosuppression, and urinary stone.
710			_9220 _aServicio de Urología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc17003.pdf _ySolicitar documento
942			_2ddc _cART _n0